HGH Fragment 176-191
GH fragment targeting fat metabolism.
Category: Metabolic
Retatrutide
Triple GLP-1/GIP/glucagon agonist; late-stage trials.
AOD-9604
Targeted lipolysis without GH-like side effects in preclinical models.
Mazdutide
Dual GLP-1/glucagon agonist; phase 3 trials.
Semaglutide
GLP-1 receptor agonist for metabolic disease and weight management.
Cagrilintide
Long-acting amylin analog; combined with semaglutide in trials.
Tirzepatide
Dual GIP/GLP-1 agonist; next-generation metabolic therapy.
Liraglutide
Daily GLP-1 agonist for type 2 diabetes and obesity.
Dulaglutide
Once-weekly GLP-1 agonist for type 2 diabetes.
Exenatide
GLP-1 agonist for type 2 diabetes management.